On May 19, local time, Hospitalar 2026 officially opened at the São Paulo Expo & Convention Center. As Latin America’s largest and most influential comprehensive medical fair, Hospitalar has evolved into a pivotal gateway for global healthcare companies seeking to connect with the Latin American market since its inception in 1994. This year’s event attracted over 1,200 exhibitors from around the world and more than 80,000 professional visitors, drawing attendees from over ten Latin American countries, including Argentina, Chile, Peru, and Colombia. The strong turnout underscores São Paulo’s role as a dynamic economic and trade hub in the region.

At this premier global healthcare event, ChoiceMMed, a subsidiary of Tianjin Chasesun Pharmaceutical Co., Ltd., unveiled a comprehensive portfolio of innovative products spanning three core areas: oximetry, respiratory care, and cardiovascular health.

Showcasing pulse oximeters in fingertip, wrist, handheld, and tabletop formats, portable oxygen concentrators, and wearable devices for remote monitoring, ChoiceMMed demonstrated its deep expertise as a global medtech player. Among the highlights was an oximeter featuring non-invasive respiratory rate measurement, attracting significant attention from Latin American healthcare professionals for its practical applications in chronic disease management. 

In the respiratory segment, the portable oxygen concentrator stood out for its lightweight design and extended battery life, offering convenient support for home oxygen therapy and outdoor mobility for patients with chronic respiratory conditions. In the cardiovascular and telemedicine segment, ChoiceMMed showcased wearable devices capable of monitoring multiple physiological parameters, such as blood oxygen, blood pressure, and ECG. These devices seamlessly sync with smart terminals via Bluetooth and wireless transmission, enabling easy data recording and remote management—a clear reflection of the company’s technological strength in smart healthcare. 

As the largest medical device market in Latin America, Brazil has a substantial and rapidly growing demand for high-frequency clinical diagnostic equipment, chronic respiratory care products, and portable home-use medical devices. ChoiceMMed's participation in this exhibition is not only a showcase of its products and technologies, but also a precise response to local market needs. Drawing on years of global market insights and lean manufacturing capabilities, ChoiceMMed has steadily built a professional and reliable brand perception and channel foundation.Empowered by Tianjin Chasesun Pharmaceutical Co., Ltd., ChoiceMMed will continue to drive innovation as a core engine, further expand its global footprint, and bring advanced medical technology to more communities around the world.